FM
BCYC

Frazier Management’s Bicycle Therapeutics BCYC Stock Holding History

Frazier Management’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-555,240
Closed -$33.8M – 9
2021
Q4 		$33.8M Buy
555,240
+112,360
+25% +$6.2M 2.6% 12
2021
Q3 		$18.4M Buy
+442,880
New +$15.5M 1.47% 21

Other funds holding BCYC

DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Frazier Management's BCYC Position: Q1 2022 in Review

Frazier Management sold out of Bicycle Therapeutics (BCYC) in Q1 2022, closing a stake of 555,240 shares — an estimated $33.8M sold.

Frazier Management first reported a position in BCYC in Q3 2021 and held it in 2 quarters. The position peaked at $33.8M in Q4 2021. 106 funds tracked by Wall St. Rank hold BCYC as of Q1 2022.

  • Frazier Management reported no remaining Bicycle Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Frazier Management sold 555,240 Bicycle Therapeutics shares in Q1 2022, an estimated $33.8M.
  • Frazier Management first reported a position in Bicycle Therapeutics in Q3 2021 and held it in 2 quarters.
  • Frazier Management's Bicycle Therapeutics position peaked at $33.8M in Q4 2021.
  • 106 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q1 2022.

Based on Frazier Management's 13F filing for Q1 2022, filed 13 May 2022.